BACKGROUNDThe cutaneous mycoses, mainly caused by dermatophyte fungi, are among the most
common fungal infections worldwide. It is estimated that 10% to 15% of the
population will be infected by a dermatophyte at some point in their lives, thus
making this a group of diseases with great public health importance.OBJECTIVETo analyze the clinical, epidemiological, and therapeutic profile of
dermatophytosis in patients enrolled at the Dermatology service of Universidade do
Estado do Pará, Brazil, from July 2010 to September 2012.METHODA total of 145 medical records of patients diagnosed with dermatophytosis were
surveyed. Data were collected and subsequently recorded according to a protocol
developed by the researchers. This protocol consisted of information regarding
epidemiological and clinical aspects of the disease and the therapy employed.RESULTSThe main clinical form of dermatophyte infection was onychomycosis, followed by
tinea corporis, tinea pedis, and tinea capitis. Furthermore, the female population
and the age group of 51 to 60 years were the most affected. Regarding therapy,
there was a preference for treatments that combine topical and systemic drugs, and
the most widely used drugs were fluconazole (systemic) and ciclopirox olamine
(topical).CONCLUSIONThis study showed the importance of recurrent analysis of the epidemiological
profile of dermatophytosis to enable correct therapeutic and preventive management
of these conditions, which have significant clinical consequences, with chronic,
difficult-totreat lesions that can decrease patient quality of life and cause
disfigurement.